Article · 1 Jul 2016
Research articlePublished 2012
Impact of MDM2 SNP309T>G Polymorphism: Increased Risk of Developing Non Small Cell Lung Cancer and Poor Prognosis in Indian Patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: MDM2 is an important negative regulator of the TP53 pathway, over expressed in many cancers as oncoprotein. Polymorphisms in the promoter region of the MDM2 gene have been shown to alter protein expression and may, thus play an important role in carcinogenesis. Aim and methods: To test our hypothesis that the MDM2 promoter polymorphisms are associated with risk of non small cell lung cancer, we conducted a hospital-based, case–control study of 136 Indian patients diagnosed with NSCLC and 136 cancer-free controls and investigated the association between genetic variation in the promoter region of MDM2 (c.–51309G4T, rs2279744:g.G4T) and the risk of developing NSCLC by tetra-primer ARMS-PCR and ASO-PCR. Results: Compared with the MDM2-2580TT genotype, we found that the MDM2-309G variant genotypes were associated with an increased risk of NSCLC in Indian patients [OR 3.88 (1.82-8.27) RR 1.94 (1.27-2.96) RD 32.6 (15.7-49.6) p 0.0004 for GG and OR 2.60 (1.49-4.57) RR 1.52 (1.20-1.93) RD 23.16 (10.3-36.0) p 0.0009 for GT genotype]. GG genotype was found to be associated with poor survival outcome of NSCLC patients and in addition significant association was observed with stage (p 0.01) and metastasis status (p 0.002) of NSCLC patients. Conclusion: Genetic polymorphism in cell cycle regulatory genes MDM2 contribute to the risk of developing NSCLC in Indian Patients. In addition G allele was associated with an increased risk and poor survival outcome than T allele.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 4 Aug 2015
Effect of hENT1 polymorphism G-706C on clinical outcomes of gemcitabine-containing chemotherapy for Chinese non-small cell lung cancer patients
Research article · 2012
Clinical and Prognostic Significance of Promoter Polymorphism (-31GC)of Anti Apoptotic Gene Survivin (BIRC5) in North India Patients with Non Small Cell Lung Cancer
Editorial · 2019
Circulating Tumor Cells Failed to Predict Prognosis Following MicroWave Ablation of Oligometastasis in EGFR-mutant Non-Small Cell Lung Cancer Patients
Conference abstract · 12 Mar 2018
Novel autoantibody signatures in plasma exosomes as potential biomarkers for diagnostics and prognosis of non-small-cell lung cancer
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Jamsheed Javid”
- BylineArticles whose byline prints “Rashid Mir”
- BylineArticles whose byline prints “M Masroor”
- BylineArticles whose byline prints “Shazia Farooq”
- BylineArticles whose byline prints “Imtiyaz Ahamad”
- BylineArticles whose byline prints “Prasant Yadav”
- BylineArticles whose byline prints “Maryam Zubari”
- BylineArticles whose byline prints “PC Ray”

